Editorial explainer
Peptide therapy in the UK
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last updated 2026-06-15
Editorial with affiliate links. We earn from purchases via outbound retailer / clinic links. How we are funded.
Peptide therapy is a broad term for using peptides, short chains of amino acids, for a health, performance or cosmetic purpose. In the UK it covers four very different things: over-the-counter cosmetic skincare peptides, ingestible collagen supplements, research peptides sold for laboratory use only, and licensed prescription medicines that are peptide-based, such as the GLP-1 weight-loss drugs. Each has a different legal status, a different evidence base and a different route to access, so the single phrase hides a lot. PeptideClear is editorial commentary, not clinical advice; any treatment decision rests with you and a UK-licensed prescriber.
The four things "peptide therapy" can mean
The most useful first step is to work out which of these you are actually looking at, because the legal position and the evidence are not transferable between them.
Cosmetic peptides
Read more about cosmetic peptidesTopical skincare peptides (copper peptides, Matrixyl) sold over the counter in the UK as cosmetics.
UK status: Legal to buy and use as cosmetics.
Ingestible collagen peptides
Read more about ingestible collagen peptidesHydrolysed collagen marketed as a food supplement for skin, joints and hair.
UK status: Legal as a food supplement.
Research peptides
Read more about research peptidesCompounds such as BPC-157, TB-500 and the growth hormone secretagogues, sold in the UK for laboratory research use only.
UK status: Sold under research-use-only framing; not licensed for human use.
Prescription peptide-based medicines
Read more about prescription peptide-based medicinesLicensed medicines that are peptides or peptide analogues, most prominently the GLP-1 weight-loss and diabetes drugs.
UK status: Prescription-only medicines (POM); a UK-licensed prescriber decides.
What the evidence does and does not support
The biggest source of confusion in peptide therapy is treating it as one thing with one evidence base. It is not. The GLP-1 peptide medicines have large published human randomised trials behind their licensed uses. Many research peptides, by contrast, have only preclinical or animal-model literature and no published human randomised trials, which is exactly why they are sold for research use rather than as treatments.
A claim like "this peptide repairs tissue in four weeks" states a human outcome that the published human evidence does not support, and that is the kind of claim that draws regulatory enforcement. A claim like "this peptide has a body of preclinical literature suggesting tissue-protective effects in animal models, with no human randomised trials published" describes the same compound accurately. We hold every research peptide page to the second standard.
If you want the per-compound detail, the research peptide encyclopedia covers each one with the evidence framed honestly.
Common questions
Frequently asked questions
What is peptide therapy?
Is peptide therapy legal in the UK?
Does peptide therapy work?
Where do people get peptide therapy in the UK?
Is peptide therapy the same as a peptide clinic?
Related reading
- Research peptide encyclopedia: every compound, evidence framed honestly
- UK research peptide retailers compared
- UK clinics directory: prescriber-led GLP-1 services
- Is tirzepatide a peptide or a GLP-1?
- Peptide glossary